# Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia

> **NCT05893836** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 555 (actual)

## Conditions studied

- Chronic Myeloid Leukaemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05893836
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-27
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 555 (ACTUAL)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05893836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05893836, "Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05893836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*